AstraZeneca PLC is 34.1x more valuable than CORCEPT THERAPEUTICS INC by market capitalization ($286.27 B vs $8.39 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CORT | AZN |
|---|---|---|
| Market cap | $8.39 B | $286.27 B |
| US-listed rank | #1039 | #45 |
| Revenue (latest FY) | $761.41M | - |
| Net income (latest FY) | $99.65M | - |
| Net margin | 13.1% | - |
| P/E (trailing FY) | 84.2 | - |
| SEC filings | 1,955 | 1,004 |
AstraZeneca PLC is 34.1x more valuable than CORCEPT THERAPEUTICS INC by market capitalization ($286.27 B vs $8.39 B).
Full pages: CORCEPT THERAPEUTICS INC and AstraZeneca PLC, or browse the full rankings.